May Aung-Htut is the Co-Head of the Molecular Therapy Laboratory at the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT). A PhD graduate from the University of New South Wales, May previously held postdoctoral positions at the UNSW and University of South Australia working on cellular aging and transcriptional regulation of programmed cell death before moving to Perth. Her current research focuses on developing therapeutic antisense oligonucleotides for various diseases, including multiple sclerosis, congenital muscular dystrophy and Pompe’s disease. Aung-Htut’s ultimate goal is to extend this research to other diseases, including rare inherited diseases and cardiovascular disease.

Dr May Aung-Htut is the Co-Head of the Molecular Therapy Laboratory at the Personalised Medicine Centre. A PhD graduate from the University of New South Wales, May previously held postdoctoral positions at the UNSW and University of South Australia working on cellular aging and transcriptional regulation of programmed cell death before moving to Perth. Her current research focuses on developing therapeutic antisense oligonucleotides for various diseases, including multiple sclerosis, congenital muscular dystrophy and Pompe’s disease. Aung-Htut’s ultimate goal is to extend this research to other diseases, including rare inherited diseases and cardiovascular disease.

View Publications    Email